Stay updated on mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial.
Sign up to get notified when there's something new on the mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial. page.

Latest updates to the mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial. page
- Check3 days agoNo Change Detected
- Check10 days agoChange Detected- Revision: v3.6.4 updated from v3.6.3 to reflect a newer page template release. This change does not modify the study content or how the study details are presented.SummaryDifference0.0%

- Check17 days agoChange DetectedA new publication citation has been added to the Publications section, documenting a 5-year update of KEYNOTE-942 in J Clin Oncol (2026). This expands the study's listed references to reflect longer-term results.SummaryDifference0.0%

- Check25 days agoChange DetectedRemoved the Melanoma topic, the related topics heading, and the MedlinePlus Genetics link from the page. This changes the navigational context and reduces access to disease-related information on the study page.SummaryDifference0.1%

- Check32 days agoChange DetectedMelanoma and related topics (MedlinePlus Genetics) were added to the page's metadata/navigation, and the site revision indicator updated from v3.6.2 to v3.6.3.SummaryDifference0.2%

- Check39 days agoChange DetectedRevision: v3.6.2 is now shown, and the terms Melanoma, related topics:, MedlinePlus Genetics, and Revision: v3.6.0 have been removed. These appear to be metadata/navigation changes rather than updates to the study content.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page adds user-help sections (How to Read a Study Record, Common Questions, How to Join a Study) and related topics, and indicates recruitment is closed with 'No longer looking for participants'. It also shows a formatting change for the Intervention/Treatment heading and a new revision note (Revision: v3.6.0).SummaryDifference0.5%

Stay in the know with updates to mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial.
Enter your email address, and we'll notify you when there's something new on the mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial. page.